Literature DB >> 9845773

Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form.

J Bourquin1, H Schmidli, P van Hoogevest, H Leuenberger.   

Abstract

Artificial Neural Networks (ANN) methodology was used to assess experimental data from a tablet compression study showing highly non-linear relationships (i.e. measurements of ejection forces) and compared to classical modelling technique (i.e. Response Surface Methodology, RSM). These kinds of relationships are known to be difficult to model using classical methods. The aim of this investigation was to quantitatively describe the achieved degree of data fitting and predicting abilities of the developed models. The comparison between the ANN and RSM was carried out both graphically and numerically. For comparing the goodness of fit, all data were used, whereas for the goodness of prediction the data were split into a learning and a validation data set. Better results were achieved for the model using ANN methodology with regard to data fitting and predicting ability. All determined ejection properties were mainly influenced by the concentration of magnesium stearate and silica aerogel, whereas the other factors showed very much lower effects. Important relationships could be recognised from the ANN model only, whereas the RSM model ignored them. The ANN methodology represents a useful alternative to classical modelling techniques when applied to variable data sets presenting non-linear relationships.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845773     DOI: 10.1016/s0928-0987(97)10028-8

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  8 in total

1.  Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance.

Authors:  Svetlana Ibrić; Milica Jovanović; Zorica Djurić; Jelena Parojcić; Slobodan D Petrović; Ljiljana Solomun; Biljana Stupar
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Application of physicochemical properties and process parameters in the development of a neural network model for prediction of tablet characteristics.

Authors:  Tamás Sovány; Kitti Papós; Péter Kása; Ilija Ilič; Stane Srčič; Klára Pintye-Hódi
Journal:  AAPS PharmSciTech       Date:  2013-02-15       Impact factor: 3.246

3.  Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.

Authors:  Zhoumeng Lin; Wei-Chun Chou; Yi-Hsien Cheng; Chunla He; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Int J Nanomedicine       Date:  2022-03-24

4.  From Heuristic to Mathematical Modeling of Drugs Dissolution Profiles: Application of Artificial Neural Networks and Genetic Programming.

Authors:  Aleksander Mendyk; Sinan Güres; Renata Jachowicz; Jakub Szlęk; Sebastian Polak; Barbara Wiśniowska; Peter Kleinebudde
Journal:  Comput Math Methods Med       Date:  2015-05-26       Impact factor: 2.238

5.  Application of Machine-Learning Algorithms for Better Understanding of Tableting Properties of Lactose Co-Processed with Lipid Excipients.

Authors:  Jelena Djuris; Slobodanka Cirin-Varadjan; Ivana Aleksic; Mihal Djuris; Sandra Cvijic; Svetlana Ibric
Journal:  Pharmaceutics       Date:  2021-05-05       Impact factor: 6.321

6.  Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks.

Authors:  Aleksander Mendyk; Paweł K Tuszyński; Sebastian Polak; Renata Jachowicz
Journal:  Drug Des Devel Ther       Date:  2013-03-27       Impact factor: 4.162

Review 7.  The Future of Pharmaceutical Manufacturing Sciences.

Authors:  Jukka Rantanen; Johannes Khinast
Journal:  J Pharm Sci       Date:  2015-08-17       Impact factor: 3.534

8.  Modeling and optimization of lucky nut biodiesel production from lucky nut seed by pearl spar catalysed transesterification.

Authors:  T F Adepoju; B Rasheed; O M Olatunji; M A Ibeh; F T Ademiluyi; B E Olatunbosun
Journal:  Heliyon       Date:  2018-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.